Syneos Health Expands Catalyst Site Program to Indonesia
February 17, 2025
MORRISVILLE, N.C., February 17, 2025 - Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, has signed an agreement with Mayapada Hospital Jakarta Selatan, expanding the Company’s clinical trial capabilities across a broad range of therapeutic areas in Indonesia.
Mayapada Hospital Jakarta Selatan now becomes part of the Syneos Health Catalyst and Site Network Partnerships program, including 125+ clinical sites and 80+ commercial site networks. Site Network Partnerships provide enhanced patient access, improved efficiencies, specialized expertise and access to diverse patient populations across all therapeutic areas and phases.Syneos Health has similar partnerships with 35 sites and 13 networks across the APAC region. Globally, the Company has 126 Catalyst Sites and 87 Networks.
Together, Syneos Health and Mayapada Hospital Jakarta Selatan play a pivotal role in supporting the clinical research ecosystem in Indonesia, and this agreement marks an important milestone to advancing research and improving patient outcomes in the country. Further, Syneos Health is collaborating with ONWARD Health Research, an organization focused on enabling hospitals to conduct clinical research in Indonesia, to collectively advance the work the companies are doing in the region.
“Together with Mayapada Hospital Jakarta Selatan, Syneos Health has embarked on an inspiring journey—transforming Mayapada from a New Clinical Research Site to a fully established Catalyst Site now ready to conduct its first clinical trial,” said Serena Chan, Head of APAC, Global Country Operations & Managing Director, SEA, Taiwan, Syneos Health. “Through this strong collaboration, we have combined our expertise and resources to build a foundation for advancing clinical research in Indonesia and are enhancing access to innovative healthcare solutions for diverse communities.”
Dr. Dini Handayani, MARS, FISQUA, FIPC, Chief Medical Officer at Mayapada Healthcare said, “We hope this collaboration will position the hospital as an internationally renowned research facility, actively educating the public on health matters, and developing treatments for specific diseases, thereby improving the health status of the Indonesian people.”
Dr. Fiktorius Kuludong, MM, Hospital Director of Mayapada Hospital Jakarta Selatan also expressed, “We hope this collaboration will encourage doctors from Mayapada Hospital Jakarta Selatan to become principal investigators in international-standard clinical trial research.”
About Syneos Health
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities.
We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients.
Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.
To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com.
Press/Media Contact:
Meg Byers
Director, External Communications
